Risk factors for early circulatory mortality in patients with schizophrenia

Kuo-Hsuan Chung1, Pao-Huan Chen1, Chian-Jue Kuo2

  • 1Department of Psychiatry and Psychiatric Research Center, Taipei Medical University Hospital, Taipei, Taiwan; Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

Psychiatry Research
|June 8, 2018
PubMed

Insights

Patients with schizophrenia face higher early mortality from cardiovascular disease (CVD). Longer antipsychotic treatment duration showed a protective effect, while higher leukocyte counts indicated increased risk.

Area of Science:

  • Medical Research
  • Psychiatry
  • Cardiology

Background:

  • Schizophrenia is linked to significantly higher mortality and reduced life expectancy.
  • Cardiovascular disease (CVD) is a leading cause of premature death in schizophrenia patients, accounting for up to 50% of cases.

Purpose of the Study:

  • To identify risk factors, particularly pathophysiological changes, associated with early circulatory mortality in schizophrenia patients.
  • To investigate the role of antipsychotic treatment duration and inflammatory markers in CVD mortality within this population.

Main Methods:

  • A multi-institutional, nested case-control study involving inpatients with schizophrenia in northern Taiwan.
  • Cases (n=79) died from CVD before age 65, compared to 158 randomly selected controls matched for age, sex, and admission.
  • Data collected via medical record reviews, including leukocyte counts and antipsychotic treatment duration.

Main Results:

  • The duration of antipsychotic treatment was significantly associated with a reduced risk of early circulatory mortality.
  • Elevated leukocyte counts during index hospitalization were significantly associated with an increased risk of early circulatory mortality.
  • Findings suggest systemic inflammation as a potential risk factor, with antipsychotic therapy, especially typical antipsychotics, potentially offering protection.

Conclusions:

  • Systemic inflammation, indicated by leukocyte count, may be a significant risk factor for premature cardiovascular death in schizophrenia.
  • Antipsychotic treatment duration, particularly with typical antipsychotics, appears to be a protective factor against early circulatory mortality in schizophrenia patients.

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.7K
Anatomy of the Circulatory System02:03

Anatomy of the Circulatory System

The human circulatory system consists of blood, blood vessels that carry blood away from the heart, around the body, and back to the heart, and the heart itself, which acts as a central pump. The systemic circuit supplies blood to the whole body, the coronary circuit supplies blood to the heart, and the pulmonary circuit supplies blood flow between the heart and lungs.
98.2K
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
332
Schizophrenia01:17

Schizophrenia

Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
998
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
644
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
635